Target Name: ZBTB7C
NCBI ID: G201501
Review Report on ZBTB7C Target / Biomarker Content of Review Report on ZBTB7C Target / Biomarker
ZBTB7C
Other Name(s): zinc finger and BTB domain-containing protein 36 | Zinc finger and BTB domain containing 7C, transcript variant 1 | Zinc finger and BTB domain-containing protein 36 | Zinc finger and BTB domain-containing protein 7C | Zinc finger protein 857C | ZNF857C | zinc finger and BTB domain containing 36 | Affected by papillomavirus DNA integration in ME180 cells protein 1 | affected by papillomavirus DNA integration in ME180 cells protein 1 | ZBT7C_HUMAN | zinc finger protein 857C | ZBTB7C variant 2 | ZBTB7C variant 1 | APM1 | Zinc finger and BTB domain-containing 7C | Zinc finger and BTB domain containing 7C, transcript variant 2 | APM-1 | ZBTB36 | B230208J24Rik | Zinc finger and BTB domain containing 36 | zinc finger and BTB domain containing 7C

ZBTB7C: A Zinc Finger Protein Regulating Gene Expression and Cellular Processes

ZBTB7C, also known as zinc finger and BTB domain-containing protein 36, is a protein that is expressed in a wide range of tissues in the human body. It is a member of the BTB domain family, which is known for their ability to interact with various transcription factors and other proteins to regulate gene expression. ZBTB7C is unique in that it is a zinc finger protein, which means that it contains a zinc finger domain in its protein sequence.

The zinc finger domain is a type of gene regulatory domain that is characterized by the presence of a zinc finger protein. This domain is known for its ability to interact with various transcription factors and other proteins to regulate gene expression. In ZBTB7C, the zinc finger domain is used to interact with the BTB2 complex, which is a protein that is involved in the regulation of stem cell proliferation and differentiation.

ZBTB7C is a protein that is expressed in a wide range of tissues in the human body, including the brain, heart, and muscle. It is also expressed in various organs and tissues, such as the liver, pancreas, and gastrointestinal tract. ZBTB7C is involved in many different cellular processes in the body, including cell signaling, DNA replication, and metabolism.

One of the ways that ZBTB7C is involved in these processes is through its role in the regulation of gene expression. ZBTB7C has been shown to interact with various transcription factors, such as BTB2, to regulate the expression of genes that are involved in cell signaling, differentiation, and metabolism. This interaction between ZBTB7C and BTB2 suggests that ZBTB7C may be a potential drug target or biomarker for the treatment of a variety of diseases.

In addition to its role in gene regulation, ZBTB7C is also involved in the regulation of cellular processes such as cell signaling, DNA replication, and metabolism. It is part of a signaling pathway that is involved in the regulation of cell proliferation and differentiation, and it has been shown to play a role in the regulation of a variety of cellular processes in the body.

Overall, ZBTB7C is a protein that is involved in a wide range of cellular processes in the human body. Its interaction with the BTB2 complex and its role in the regulation of gene expression suggest that it may be a potential drug target or biomarker for the treatment of a variety of diseases. Further research is needed to fully understand the role of ZBTB7C in cellular processes and its potential as a drug target or biomarker.

Protein Name: Zinc Finger And BTB Domain Containing 7C

Functions: May be a tumor suppressor gene

The "ZBTB7C Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about ZBTB7C comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

ZBTB7C-AS2 | ZBTB8A | ZBTB8B | ZBTB8OS | ZBTB8OSP1 | ZBTB9 | ZC2HC1A | ZC2HC1B | ZC2HC1C | ZC3H10 | ZC3H11A | ZC3H11B | ZC3H11C | ZC3H12A | ZC3H12A-DT | ZC3H12B | ZC3H12C | ZC3H12D | ZC3H13 | ZC3H14 | ZC3H15 | ZC3H18 | ZC3H18-AS1 | ZC3H3 | ZC3H4 | ZC3H6 | ZC3H7A | ZC3H7B | ZC3H8 | ZC3HAV1 | ZC3HAV1L | ZC3HC1 | ZC4H2 | ZCCHC10 | ZCCHC12 | ZCCHC13 | ZCCHC14 | ZCCHC14-DT | ZCCHC17 | ZCCHC18 | ZCCHC2 | ZCCHC24 | ZCCHC3 | ZCCHC4 | ZCCHC7 | ZCCHC8 | ZCCHC9 | ZCRB1 | ZCWPW1 | ZCWPW2 | ZDBF2 | ZDHHC1 | ZDHHC11 | ZDHHC11B | ZDHHC12 | ZDHHC12-DT | ZDHHC13 | ZDHHC14 | ZDHHC15 | ZDHHC16 | ZDHHC17 | ZDHHC18 | ZDHHC19 | ZDHHC2 | ZDHHC20 | ZDHHC20P1 | ZDHHC20P2 | ZDHHC21 | ZDHHC22 | ZDHHC23 | ZDHHC24 | ZDHHC3 | ZDHHC4 | ZDHHC5 | ZDHHC6 | ZDHHC7 | ZDHHC8 | ZDHHC8BP | ZDHHC9 | ZEB1 | ZEB1-AS1 | ZEB2 | ZEB2-AS1 | ZER1 | ZFAND1 | ZFAND2A | ZFAND2B | ZFAND3 | ZFAND4 | ZFAND5 | ZFAND6 | ZFAS1 | ZFAT | ZFAT-AS1 | ZFC3H1 | ZFHX2 | ZFHX3 | ZFHX4 | ZFHX4-AS1 | ZFP1